v3.26.3
Related party transactions (Details) - CHF (SFr)
3 Months Ended 6 Months Ended 12 Months Ended
Apr. 02, 2024
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2024
Related party transactions            
Salaries, other short-term employee benefits and post-employment benefits   SFr 216,591 SFr 99,864 SFr 438,143 SFr 197,156  
Share-based compensation   5,654 18,910 13,980 43,428  
Key management compensation   222,245 118,774 452,123 240,584  
Increase (decrease) in total compensation costs for key management   100,000   200,000    
Neurosterix US Holdings LLC            
Related party transactions            
Percentage of equity interest received 20.00%          
Discontinued operations as disclosed below            
Related party transactions            
Cash in from Neurosterix Pharma Sarl sale SFr 5,000,000         SFr 5,000,000
Discontinued operations as disclosed below | Neurosterix US Holdings LLC            
Related party transactions            
Percentage of equity interest received 20.00%         20.00%
Fair value of Neurosterix US Holdings LLC's participation SFr 9,420,000         SFr 9,400,000
Board of Directors and Executive Management            
Related party transactions            
Net payable   100,000 100,000 100,000 100,000  
Neurosterix Pharma Sarl            
Related party transactions            
Net payable   47,461   47,461    
Fair value of service agreement   SFr 9,948 SFr 34,505 SFr 17,639 SFr 105,560